Viridian Therapeutics, Inc. (VRDN)

Viridian Therapeutics Revenue

Viridian Therapeutics had revenue of $141.00K in the quarter ending March 31, 2026, with 95.83% growth. This brings the company's revenue in the last twelve months to $70.84M, up 30,701.30% year-over-year. In the year 2025, Viridian Therapeutics had annual revenue of $70.85M with 23,359.93% growth.

• Revenue (ttm): $70.84M
• Revenue Growth: +30,701.30%
• P/S Ratio: 26.84
• Revenue / Employee: $281,421
• Employees: 252
• Market Cap: 1.90B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	70.85M	70.55M	23,359.93%
Dec 31, 2024	302.00K	-12.00K	-3.82%
Dec 31, 2023	314.00K	-1.46M	-82.28%
Dec 31, 2022	1.77M	-1.19M	-40.20%
Dec 31, 2021	2.96M	1.91M	182.19%
Dec 31, 2020	1.05M	-3.41M	-76.46%
Dec 31, 2019	4.46M	-3.93M	-46.80%
Dec 31, 2018	8.39M	4.38M	109.49%
Dec 31, 2017	4.00M	526.00K	15.13%
Dec 31, 2016	3.48M	-	-
Dec 31, 2015	-	-	-
Dec 31, 2014	-	-	-
Dec 31, 2013	-	-	-
Dec 31, 2012	-	-	-
Dec 31, 2011	-	-	-

Data Source: Fiscal.ai Last updated: May 5, 2026

Revenue data is provided by Fiscal.ai and updates within minutes after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 20, 2026

Data Sources Report a data error